pindolol has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, Y | 1 |
Zhou, X | 1 |
Zhu, D | 1 |
Chen, J | 1 |
Qin, B | 1 |
Zhang, Y | 1 |
Wang, X | 1 |
Yang, D | 1 |
Meng, H | 1 |
Luo, Q | 1 |
Xie, P | 1 |
1 review available for pindolol and Depressive Disorder, Treatment-Resistant
Article | Year |
---|---|
Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
Topics: Adult; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Pindolol; Psychi | 2015 |